This study aimed to elucidate how FK506 binding protein 5 impairment affects the GM in HFD-induced metabolic dysfunction-associated fatty liver disease and metabolic dysfunction-associated steatotic liver disease (MASLD). This evidence concerns the gene FKBP5 and metabolic dysfunction-associated steatotic liver disease.